10088-91-2

Upstream product

• 617-48-1 malic acid 
• 102154-42-7 6-hydroxy-4-methoxy-2,3-dihydro-benzofuran-7-carboxylic acid 
• 100374-69-4 4-methoxy-7-oxo-2,3-dihydro-7H-furo[3,2-g]chromene-9-carboxylic acid 
• 103988-54-1 6-hydroxy-4-methoxy-2,3-dihydro-benzofuran-7-carboxylic acid methyl ester 
• 19722-76-0 methyl-2,6-dihydroxy-4-methoxybenzoate 
• 107625-56-9 6-acetoxy-4-methoxy-2,3-dihydro-benzofuran-7-carboxylic acid methyl ester 
• 101094-34-2 3,6-diacetoxy-4-methoxy-benzofuran-7-carboxylic acid methyl ester 

Relevant academic research and scientific papers

Reduced and quaternized psoralens as photo-activated therapeutics

The invention features phototherapeutic compositions comprising Type 1, Type 2, or Type 3 psoralens and methods of using such compounds for treatment of proliferative diseases of skin, blood and bone marrow.

7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor

A photochemotherapeutic compound of the formula STR1 wherein (i) n is zero, W is a (C1-16) alkyl, alkenyl, or alkynyl linear or branched chain hydrocarbon, having no more than four O, N, or S atoms in or attached to the chain; or (ii) n is 1, W is CR or CR2, and R, R', and R" are independently H or CH3 ; or (iii) N is 2, W is CR or CR2, and R, R', and R" are independently H or CH3 ; and A, B, C, and D are independently selected from hydrogen, alkyl, aryl, halogen, amino, aminoalkyl, nitro, alkoxy, aryloxy, hydroxy, carboxy, haloalkyl, or haloalkoxy, particularly compounds of the foregoing structure in which W is a charged substiuent and n=0 or 1.